Anika Therapeutics Spars With Caligan Over Corporate Future
Anika Therapeutics shareholder Caligan Partners urged the biotech company in a letter Tuesday to consider "urgent changes" to its operations and structure, including a reorganization that could include a transition into...To view the full article, register now.
Already a subscriber? Click here to view full article